Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Use should be discontinued upon observance of any untoward reaction
There are two common formats : a pre-blended vial (most often 12.5 mg retatrutide + 2.5 mg cagrilintide in one vial), or two separate vials dosed together
Research in burn models shows GHK-Cu increases healing rates by up to 33%, partly through enhanced angiogenesis that helps burned tissue regrow blood vessels despite cauterization effects
It also promotes collagen production
Results build over several months, so consistent use is key
DSIP has been part of the shifting regulatory review process that governs which peptides may be eligible for pharmacy compounding, and as of this writing there is no established compounding pathway that would make it routinely available the way an approved or clearly compoundable medication would be
